Shatavari: What the Animal Evidence Can and Cannot Say

Table of Contents

1. The Evidence Ladder
2. What the Reviews Summarise
3. Farm Animals: The Goat Study
4. Fish: Tilapia and Goldfish
5. Worms: Lifespan and Parkinson's Models
6. Cells in a Dish
7. Computer Models
8. Why Results Do Not Transfer Automatically
9. Where Human Trials Now Take Over
10. How to Read a Shatavari Claim
11. Key Research Papers
12. Connections

The Evidence Ladder

Medical evidence is often pictured as a ladder, with the strongest rungs at the top:

1. Computer modelling (in silico): predicts whether a molecule might fit a target.
2. Cell culture (in vitro): tests an effect on isolated cells, usually at controlled concentrations.
3. Simple animals: worms and fish, useful for screening.
4. Mammals: rats, mice, and larger animals, which share more of human physiology.
5. Small human studies: physiology studies and pilot trials.
6. Randomised controlled trials in people: the strongest single-study design for showing that a treatment causes a benefit.
7. Systematic reviews of several independent trials.

Shatavari research is heavily concentrated on the lower rungs. It has a few trials on the sixth rung, almost all published since 2021, and nothing yet on the seventh: no systematic review pooling independent Shatavari trials appears in the research behind this page.

What the Reviews Summarise

Much of the rodent research on Shatavari reaches readers through reviews rather than individual papers. Two recent ones are typical:

• A 2023 review in Heliyon on the plant's "adaptogenic property" describes it as alleviating depression "by modulating the HPA axis" (the body's stress-hormone system), "increasing BDNF levels" (a protein that supports nerve cells), and changing brain chemistry and antioxidant enzymes "in distinct brain regions (i.e., hippocampus, prefrontal cortex, amygdala, and hypothalamus)." Measurements in named brain regions come from animal experiments. The review concludes that the plant "could be a new generation antidepressant."
• A 2021 review in Neurochemistry International lists adaptogenic, neuroprotective, antioxidant, anti-inflammatory and nootropic activity "under preclinical and clinical settings," but adds that "the lack of standardization has been a major hurdle," and that "rigorous standardized clinical trials, fixing dosages, and determining contraindications" are still needed.

The individual rodent studies behind these summaries are not cited on this page; the reviews are. The key point is the gap between the confident language of the first review's conclusion and the evidence type behind it: no antidepressant trial in people appears in the research behind this wing.

Farm Animals: The Goat Study

In a 2023 study, lactating Beetal goats were fed a composite extract of four plants — horse gram seeds, Shatavari root, rohitaka bark and pomegranate peel — at 20 grams per kilogram of diet, in a 70-day experiment. Compared with control goats, the supplemented goats produced more milk, with higher protein and lactose, lower somatic cell counts (a marker of udder inflammation), better feed digestibility and improved immune responses. A test-tube arm of the study also found lower methane production from rumen fluid.

What it can say: this four-plant mixture improved milk yield in goats under these conditions.

What it cannot say: anything about Shatavari on its own, because four plants were given together; or anything about women, because a goat's rumen digests plant material in a fundamentally different way from the human stomach. It is sometimes cited as support for the galactagogue claim, which overstates it.

Fish: Tilapia and Goldfish

Nile tilapia. A 2024 veterinary study exposed tilapia to the insecticide deltamethrin, which is highly toxic to fish, and fed some groups a water extract of Shatavari at 10, 20 or 30 grams per kilogram of feed for 21 days. The extract reduced the rise in blood markers of heart and liver injury, helped restore electrolytes and antioxidant enzymes, and lessened heart-tissue damage seen under the microscope.

Goldfish. A 2013 aquaculture study tested vaccines against the fish pathogen Aeromonas hydrophila, with and without Shatavari as an "immunoadjuvant" (a substance added to boost a vaccine's effect). Unvaccinated goldfish all died within seven days of infection; vaccines improved survival, and adding Shatavari further reduced bacterial load and improved several immune measures.

What these can say: Shatavari extract has biological activity in fish, and may be of practical use in fish farming.

What they cannot say: that Shatavari protects the human heart, counters pesticide poisoning in people, or boosts human vaccines. Doses given as grams per kilogram of fish feed do not translate to human doses.

Worms: Lifespan and Parkinson's Models

A 2017 study treated the roundworm Caenorhabditis elegans with purified shatavarin IV. The worms lived longer, showed less oxidative damage, and switched on stress-response genes; in a worm model of Parkinson's disease, alpha-synuclein clumping fell and dopamine rose.

What it can say: shatavarin IV affects stress-response pathways in a simple animal, and is a candidate for further ageing and neurodegeneration research.

What it cannot say: anything about human lifespan or Parkinson's disease. C. elegans lives only a few weeks and is a very simple animal; results in worms often fail to carry over to mammals, let alone people.

Cells in a Dish

Three recent cell studies show the range:

• Rat ovarian cells (2024): shatavarin IV reduced oxidative stress caused by the plasticiser DEHP in granulosa cells, and restored the activity of genes involved in making steroid hormones.
• Human stomach-cancer cells (2024): shatavarin IV slowed cell growth and invasion under high-glucose conditions.
• HIV-1 (2024): root extracts reduced viral replication in cell lines and human blood immune cells, and protected mitochondria in infected cells.

What these can say: the compounds are biologically active at the concentrations used, and the experiments suggest mechanisms worth exploring.

What they cannot say: whether those concentrations can be reached in human tissue after swallowing the root, whether the effects survive in a whole organism, or whether they are safe at that level. A cancer-cell result is a long way from a cancer treatment.

Computer Models

A 2024 molecular-docking study modelled seven shatavarins binding to oestrogen, progesterone, FSH and LH receptors, and a 2024 HIV study modelled shatavarin IV binding to viral enzymes. Docking is fast and cheap, and good for choosing which compounds to test.

What it can say: a molecule's shape is compatible with a binding pocket.

What it cannot say: whether the molecule activates or blocks the target, whether it gets there in a living body, or whether it matters at realistic doses. Online claims that Shatavari is "estrogenic" frequently lean on this kind of result; it is a prediction, not a measurement.

Why Results Do Not Transfer Automatically

Four recurring problems separate preclinical findings from human benefit:

• Dose. Animal studies often use amounts per kilogram of body weight far higher than any human product supplies; fish studies dose by feed weight; cell studies use fixed concentrations that may never be reached in blood.
• Absorption and metabolism. Large saponin molecules may be broken down by gut bacteria or poorly absorbed; a compound active in a dish may never reach its target in a person. No human absorption study of the shatavarins appears in the research behind this page.
• The preparation. Different studies used different extracts, a purified compound, or a multi-plant mixture. A 2007 review noted "an incomplete understanding about the interaction/synergy" of Shatavari with other plants in mixtures.
• The question. Animal models of depression, ageing or toxicity are designed to be measurable, not to mirror the human condition fully.

As a 2003 review put it, beyond a few reports, "no scientific proof justifying" the traditional uses of the root extract was available at the time; animal and laboratory work helped generate hypotheses, which is its proper role.

Where Human Trials Now Take Over

For a few questions, Shatavari now has human data, and those data take precedence over the animal and cell work:

• Milk supply: a 2025 placebo-controlled trial in 120 new mothers reported more milk at 72 hours. The goat study adds nothing to this.
• Menopausal symptoms: several trials report improvements; in one, the significant result belonged to a combination with ashwagandha.
• Muscle: a six-week trial in 20 older women found a small gain in grip strength but not leg strength.
• Bone: two trials disagree on bone-turnover markers.
• Hormones: one trial reported rises in estradiol and FSH; another reported normal levels maintained; a third, in PCOS, found no hormone differences. These real measurements matter more than any docking score.

For everything else on the benefits list — mood, memory, immunity, ulcers, cancer, viral infection, ageing — the evidence remains preclinical.

How to Read a Shatavari Claim

When a product page or article makes a claim, three questions sort most of them quickly:

1. Was it in people? If the study was in rats, fish, worms, cells or a computer, the claim is a hypothesis about humans.
2. Was it Shatavari alone? Mixtures with other herbs, including ashwagandha, cannot be credited to Shatavari.
3. Was there a placebo group? Symptom scores in menopause and stress can improve on placebo too; only a comparison with placebo shows an added effect.

The other deep dives apply these questions to the lactation and menopause and reproductive claims, and to the plant chemistry.

Key Research Papers

1. Singh N, Garg M, Prajapati P, et al. Adaptogenic property of Asparagus racemosus: Future trends and prospects. Heliyon. 2023;9(4):e14932. PubMed PMID: 37095959
2. Majumdar S, Gupta S, Prajapati SK, et al. Neuro-nutraceutical potential of Asparagus racemosus: A review. Neurochemistry international. 2021;145:105013. PubMed PMID: 33689806
3. Shilwant S, Hundal JS, Singla M, et al. Ruminal fermentation and methane production in vitro, milk production, nutrient utilization, blood profile, and immune responses of lactating goats fed polyphenolic and saponin-rich plant extracts. Environmental science and pollution research international. 2023;30(4):10901-10913. PubMed PMID: 36087183
4. Vineetha VP, Tejaswi HN, Sooraj NS, et al. Implications of deltamethrin on hematology, cardiac pathology, and gene expression in Nile tilapia (Oreochromis niloticus) and its possible amelioration with Shatavari (Asparagus racemosus). Veterinary research communications. 2024;48(2):811-826. PubMed PMID: 37930611
5. Thanga Viji V, Deepa K, Velmurugan S, et al. Vaccination strategies to protect goldfish Carassius auratus against Aeromonas hydrophila infection. Diseases of aquatic organisms. 2013;104(1):45-57. PubMed PMID: 23670079
6. Smita SS, Raj Sammi S, Laxman TS, et al. Shatavarin IV elicits lifespan extension and alleviates Parkinsonism in Caenorhabditis elegans. Free radical research. 2017;51(11-12):954-969. PubMed PMID: 29069955
7. Pandey V, Sharma A, Tiwari S, et al. Shatavarin-IV rescues the Di (2-ethylhexyl) phthalate (DEHP) induced oxidative stress in rat granulosa cells in vitro. Reproductive toxicology (Elmsford, N.Y.). 2024;130:108737. PubMed PMID: 39490591
8. Chatterjee A, Roy T, Kumar Mishra V, et al. Shatavarin-IV, a steroidal saponin from Asparagus racemosus, inhibits cell cycle progression and epithelial-to-mesenchymal transition in AGS cells under hyperglycemic conditions. Steroids. 2024;210:109487. PubMed PMID: 39106908
9. Jadaun P, Harshithkumar R, Seniya C, et al. Mitochondrial resilience and antioxidant defence against HIV-1: unveiling the power of Asparagus racemosus extracts and Shatavarin IV. Frontiers in microbiology. 2024;15:1475457. PubMed PMID: 39507335
10. Arora N, Banerjee AK. Molecular docking analysis of shatavarins with female hormonal receptors. Bioinformation. 2024;20(7):775-780. PubMed PMID: 39309564
11. Goyal RK, Singh J, Lal H. Asparagus racemosus--an update. Indian journal of medical sciences. 2003;57(9):408-14. PubMed PMID: 14515032
12. Bopana N, Saxena S. Asparagus racemosus--ethnopharmacological evaluation and conservation needs. Journal of ethnopharmacology. 2007;110(1):1-15. PubMed PMID: 17240097
13. Singh R. Asparagus racemosus: a review on its phytochemical and therapeutic potential. Natural product research. 2016;30(17):1896-908. PubMed PMID: 26463825
14. Ajgaonkar A, Debnath T, Bhatnagar S, et al. Shatavari (Asparagus racemosus Willd) root extract for postpartum lactation: A randomised, double-blind, placebo-controlled study. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology. 2025;45(1):2564168. PubMed PMID: 41055223
15. O'Leary MF, Jackman SR, Sabou VR, et al. Shatavari Supplementation in Postmenopausal Women Improves Handgrip Strength and Increases Vastus lateralis Myosin Regulatory Light Chain Phosphorylation but Does Not Alter Markers of Bone Turnover. Nutrients. 2021;13(12). PubMed PMID: 34959836

PubMed Topic Searches

1. PubMed: Shatavari studies in rats
2. PubMed: Shatavari antidepressant research
3. PubMed: Shatavari adaptogen research
4. PubMed: Shatavari immune research

Back to Table of Contents

Connections

• All Herbs
• Calming and Hormonal Herbs — the category this herb sits in
• Shatavari (Asparagus racemosus) — the main topic page for the plant
• Shatavari: Benefits Deep Dive — the evidence hub
• Breast Milk and Lactation Claims — where a human trial exists
• Menopause and Female Reproductive Health — the human trials in women
• Shatavarins and Plant Chemistry — the compounds tested in cells and worms
• Adaptogens and Nootropics — the herbs marketed as adaptogens
• Ashwagandha: Stress and Anxiety — an adaptogen claim with more human trials
• Tinospora: Immune Claims and the Rasayana Tradition — another rasayana herb, examined
• Silk Cotton: the Reproductive-Tonic Claim — a similar root-tonic claim
• Asparagus — the garden vegetable in the same genus

Back to Table of Contents